Inventor · disambiguated record
Haiwei Xu
Also filed as: XU HAIWEI
5 granted patents·2 pending applications·0 citations·filing 2011–2021
60Inventor score
Top patents by PatentIndex Score
7 records- 0148US2023277508A1Use of compound as cyp2e1 inhibitorSHANGHAI LING XI BIOTECHNOLOGY DEV CO LTD·Filed 2021·Application pending·0 cites
- 0245US9636324B2Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virusUNIV ZHENGZHOU·Filed 2016·Granted May 2, 2017·0 cites·6 claims
- 0344US9388169B2Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virusDAI GUIFU·Filed 2013·Granted Jul 12, 2016·0 cites·5 claims
- 0441US11369584B2Andrographolide derivatives and method of using the same for treatment or prevention of fibrosisUNIV ZHENGZHOU·Filed 2019·Granted Jun 28, 2022·0 cites·12 claims
- 0539US11279695B2Andrographolide compound and method for treatment or prevention of fibrotic disease using the sameUNIV ZHENGZHOU·Filed 2020·Granted Mar 22, 2022·0 cites·13 claims
- 0633US9198894B2Uses of 15-benzylidene-14-deoxy-11,12-didehydroandrographolide derivatives in the preparation of antineoplastic drugsWU FENGJUAN·Filed 2011·Granted Dec 1, 2015·0 cites·10 claims
- 0727US2014187627A1Uses of c15-substituted andrographolide derivatives in the preparation of anti-hepatitis b virus medicamentDAI GUIFU·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haiwei Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →